• Consensus Rating: Hold
  • Consensus Price Target: $1.43
  • Forecasted Upside: 4.00%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.38
▲ +0.005 (0.36%)

This chart shows the closing price for SHCR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sharecare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHCR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHCR

Analyst Price Target is $1.43
▲ +4.00% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Sharecare in the last 3 months. The average price target is $1.43, with a high forecast of $1.43 and a low forecast of $1.43. The average price target represents a 4.00% upside from the last price of $1.38.

This chart shows the closing price for SHCR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 contributing investment analysts is to hold stock in Sharecare. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/20/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/18/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/16/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/15/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/14/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/14/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/24/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$1.00 ➝ $1.43Low
6/21/2024Canaccord Genuity GroupDowngradeStrong-Buy ➝ HoldLow
6/21/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Hold$2.00 ➝ $1.43Low
5/21/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$2.00 ➝ $2.00Low
4/15/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$1.50 ➝ $1.00Low
4/1/2024BTIG ResearchDowngradeBuy ➝ NeutralLow
3/30/2023Morgan StanleyLower TargetEqual Weight$2.50 ➝ $2.00Low
11/11/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$4.00 ➝ $3.00Low
10/5/2022BTIG ResearchLower TargetBuy$8.00 ➝ $5.00Low
9/21/2022The Goldman Sachs GroupBoost TargetNeutral$1.50 ➝ $2.10Low
8/19/2022Canaccord Genuity GroupLower Target$5.00 ➝ $4.00Low
7/20/2022Morgan StanleyInitiated CoverageEqual Weight$2.50Low
4/22/2022BTIG ResearchReiterated RatingBuy$10.00High
4/1/2022Canaccord Genuity GroupLower Target$12.00 ➝ $6.00High
4/1/2022BTIG ResearchLower TargetBuy$15.00 ➝ $10.00High
4/1/2022The Goldman Sachs GroupLower TargetNeutral$4.50 ➝ $4.00High
2/11/2022The Goldman Sachs GroupInitiated CoverageNeutral$4.50High
7/28/2021BTIG ResearchInitiated CoverageBuy$15.00High
(Data available from 7/15/2019 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/16/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/17/2024
  • 3 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
4/16/2024
  • 5 very positive mentions
  • 44 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
5/16/2024
  • 0 very positive mentions
  • 48 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/15/2024
  • 3 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/15/2024

Current Sentiment

  • 3 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Sharecare logo
Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.
Read More

Today's Range

Now: $1.38
Low: $1.37
High: $1.38

50 Day Range

MA: $0.99
Low: $0.68
High: $1.38

52 Week Range

Now: $1.38
Low: $0.48
High: $1.80

Volume

1,780,700 shs

Average Volume

2,793,461 shs

Market Capitalization

$498.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.5

Frequently Asked Questions

What sell-side analysts currently cover shares of Sharecare?

The following sell-side analysts have issued stock ratings on Sharecare in the last twelve months: BTIG Research, Canaccord Genuity Group Inc., and Morgan Stanley.
View the latest analyst ratings for SHCR.

What is the current price target for Sharecare?

2 Wall Street analysts have set twelve-month price targets for Sharecare in the last year. Their average twelve-month price target is $1.43, suggesting a possible upside of 4.0%. Morgan Stanley has the highest price target set, predicting SHCR will reach $1.43 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $1.43 for Sharecare in the next year.
View the latest price targets for SHCR.

What is the current consensus analyst rating for Sharecare?

Sharecare currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SHCR, but not buy more shares or sell existing shares.
View the latest ratings for SHCR.

What other companies compete with Sharecare?

How do I contact Sharecare's investor relations team?

Sharecare's physical mailing address is 660 MADISON AVENUE 12TH FLOOR, NEW YORK NY, 10065. The company's listed phone number is 404-671-4000 and its investor relations email address is [email protected]. The official website for Sharecare is www.sharecare.com. Learn More about contacing Sharecare investor relations.